GH1 and neoplasm: Elevated release of cytokines like interleukin-1, interleukin-6, and tumor necrosis factor α, disrupted hormone levels including growth hormones and estrogen, and alterations in the tumor microenvironment in HCC patients may all impair skeletal muscle function [66].